Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PYGB | P11216 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 6/20 | 0.34 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | PRKCG | P05129 | 1/20 | 0.34 |
| ▸ | PRKCB | P05771 | 1/20 | 0.34 |
| ▸ | PRKCH | P24723 | 1/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.34 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2122988 | 1.00 | MAPK1 (0.44) | MAPK1PYGBGBA1PTPN1PRKCA | |
| SCHEMBL2589263 | 0.88 | MAPK1 (0.38) | MAPK1PYGBPTPN1PRKCAPRKD3 | |
| SCHEMBL2589260 | 0.88 | MAPK1 (0.38) | MAPK1PYGBPTPN1PRKCAPRKD3 | |
| SCHEMBL1279530 | 0.87 | MAPK1 (0.40) | MAPK1PYGBPRKCAGBA2PRKD3 | |
| SCHEMBL17781741 | 0.83 | PYGB (0.43) | MAPK1PYGB | |
| SCHEMBL1173142 | 0.78 | PRKCA (0.39) | MAPK1PYGBPRKCA | |
| SCHEMBL1173608 | 0.78 | PRKCA (0.39) | MAPK1PYGBPRKCA | |
| SCHEMBL28575710 | 0.77 | PYGB (0.48) | PYGB | |
| SCHEMBL5062195 | 0.77 | PYGB (0.48) | PYGB | |
| SCHEMBL5149118 | 0.77 | MAPK1 (0.39) | MAPK1PYGBGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024028283-A1 | VESICLES BASED ON GLUCOSE-DERIVED SURFACTANTS AND PHYTOSTEROLS | NANOMOL TECHNOLOGIES, S.L. (ES) | 2024-02-08 | — | — | WO | claimed |
| CN-118159250-A | Blocked emulsion toothpaste compositions | 宝洁公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118103025-A | Blocked emulsion toothpaste compositions comprising fluoride | 宝洁公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118103017-A | Blocked emulsion toothpaste compositions | 宝洁公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024028283-A1 | VESICLES BASED ON GLUCOSE-DERIVED SURFACTANTS AND PHYTOSTEROLS | NANOMOL TECHNOLOGIES, S.L. (ES) | 2024-02-08 | — | — | WO | disclosed |
| US-20230134577-A1 | Jammed Emulsion Toothpaste Compositions Comprising Fluoride | THE PROCTER & GAMBLE COMPANY | 2023-05-04 | — | — | US | disclosed |
| US-20230112138-A1 | Jammed Emulsion Toothpaste Compositions | THE PROCTER & GAMBLE COMPANY | 2023-04-13 | — | — | US | disclosed |
| US-20230104834-A1 | Jammed Emulsion Toothpaste Compositions | THE PROCTER & GAMBLE COMPANY | 2023-04-06 | — | — | US | disclosed |
| US-20230107290-A1 | Jammed Emulsion Toothpaste Compositions | THE PROCTER & GAMBLE COMPANY | 2023-04-06 | — | — | US | disclosed |
| WO-2023044469-A1 | JAMMED EMULSION TOOTHPASTE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2008006820-A1 | HAIR COLORING AGENT | HENKEL AG & CO. KGAA (DE) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008003686-A1 | OXIDATION DYES FOR DYEING KERATIN FIBERS CONTAINING ATMOSPHERIC OXYGEN AS THE ONLY OXIDIZING AGENT | HENKEL AG & CO. KGAA (DE) | 2008-01-10 | — | — | WO | disclosed |
| WO-2007140856-A1 | OXIDATIVE HAIR TREATMENT WITH REDUCED HAIR DAMAGE | HENKEL AG & CO. KGAA (DE) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007087978-A1 | AUXILIARY AGENT FOR STYLISHLY COLOURING KERATIN-CONTAINING FIBRES | HENKEL AG & CO. KGAA (DE) | 2007-08-09 | — | — | WO | disclosed |
| EP-1800654-A2 | Reduction of ageing of hair | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1791516-A1 | USE OF ALKYL-/ALKENYL-OLIGOGLYCOSIDE DERIVATIVES IN AGENTS FOR TREATING KERATIN FIBRES | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-06-06 | — | — | EP | disclosed |
| WO-2007051527-A1 | WASHING-ACTIVE PIT EMULSIONS | HENKEL AG & CO. KGAA (DE) | 2007-05-10 | — | — | WO | disclosed |
| EP-1762220-A2 | Composition for dyeing keratinous fibres comprising polymers of low molecular weight | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2006125619-A1 | HAIR DYE COMPRISING ALOE COMPONENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2005120442-A1 | USE OF ALKYL-/ALKENYL-OLIGOGLYCOSIDE DERIVATIVES IN AGENTS FOR TREATING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230107290-A1 | Jammed Emulsion Toothpaste Compositions | PLIN3, MPO, POLD1 | MAPK1 1377/4885PYGB 4868/4885GBA1 1513/4885 |
| US-20230112138-A1 | Jammed Emulsion Toothpaste Compositions | KATNA1, SMARCD1, SMARCD2 | MAPK1 1229/4885PYGB 4872/4885GBA1 2397/4885 |
| US-20230134577-A1 | Jammed Emulsion Toothpaste Compositions Comprising Fluoride | FLNA, POLR1C, ACTN1 | MAPK1 1552/4885PYGB 4209/4885GBA1 1457/4885 |
| US-20230104834-A1 | Jammed Emulsion Toothpaste Compositions | MPO, POLM, LPO | MAPK1 1442/4885PYGB 4751/4885GBA1 2235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.